논문 목록
2건-
Plasma concentrations of monoethylglycinexylidide during and after breast augmentation.
MEGX (monoethylglycinexylidide) is the main metabolite of lidocaine and is 83 percent as potent as an antiarrhythmic drug and with the same toxicity as lidocaine. In this study, plasma levels of MEGX were measured in 10 other wise healthy w…
-
Plasma concentrations of lidocaine and alpha1-acid glycoprotein during and after breast augmentation.
Plasma levels of lidocaine and the main binding proteins of lidocaine in plasma alpha1-acid glycoprotein (AAG) and albumin were measured in 10 otherwise healthy women during and after breast augmentation. A total dose of 825 to 1280 mg of 0…